Feasibility study of clinical sequence in adult malignant lymphoma.
Not Applicable
- Conditions
- Malignant lymphoma
- Registration Number
- JPRN-UMIN000033144
- Lead Sponsor
- Agency for Medical Research and Development; Program for an Integrated Database of Clinical and Genomic Information; Horibe research team.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients enrolled in another critical trials for treatment. 2) Patients who can not obtain enough amount of DNA samples for genome analyses. 3) A subject considered as an inappropriate participant for the current study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Ratio of potentially actionable findings(PAF), used as a feedback to the attending physician
- Secondary Outcome Measures
Name Time Method